Jul 10, 2026 06:45AM
Jul 9, 2026 07:02AM
Jul 6, 2026 12:06PM
Jul 6, 2026 12:05PM
Jun 23, 2026 06:40AM
Jun 17, 2026 06:49AM
Jun 17, 2026 04:19AM Opus Genetics (IRD) Reiterated at Market Outperform by Citizens after R&D Day
Jun 16, 2026 04:06PM
Jun 15, 2026 05:11AM
Jun 4, 2026 06:10AM
May 21, 2026 06:19AM
May 13, 2026 05:06AM
May 12, 2026 07:18AM
May 5, 2026 04:21AM Opus Genetics (IRD) Reiterated at Market Outperform by Citizens
May 4, 2026 10:14AM
Apr 28, 2026 02:25AM
Apr 21, 2026 06:10AM
Apr 6, 2026 07:01AM
Mar 30, 2026 06:14AM
Mar 16, 2026 06:15AM
Mar 12, 2026 06:48AM Opus Genetics (IRD) PT Raised to $10 at Wedbush
Mar 11, 2026 09:17AM
Mar 11, 2026 06:09AM
Feb 25, 2026 06:59AM
Feb 12, 2026 07:48AM
Jan 27, 2026 07:01AM
Jan 20, 2026 05:06AM
Jan 8, 2026 07:07AM Opus Genetics submits drug application, advances gene therapy trials
Dec 10, 2025 01:11AM
Dec 1, 2025 08:46AM
Nov 25, 2025 03:54AM
Nov 6, 2025 07:03AM
Oct 29, 2025 06:54AM
Oct 16, 2025 07:53AM
Oct 1, 2025 06:55AM H.C. Wainwright Reiterates Buy Rating on Opus Genetics (IRD)
Aug 18, 2025 08:01AM
Aug 13, 2025 06:13PM
Jul 24, 2025 06:42AM
Jun 26, 2025 06:56AM
Jun 25, 2025 05:19PM
Jun 17, 2025 06:40AM
Jun 2, 2025 08:00AM Opus Genetics (IRD) Announces LYNX-2 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients
May 15, 2025 08:01AM
May 6, 2025 08:03AM
Apr 11, 2025 08:54AM
Apr 8, 2025 08:01AM
Apr 8, 2025 06:56AM
Apr 1, 2025 06:51AM
Mar 21, 2025 09:12AM Opus Genetics (IRD) Prices $20M Share Offering, Concurrent Private Placement with Proceeds of Over $20M
Mar 19, 2025 03:57PM

430,616 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All